• europages
  • >
  • COMPANIES - SUPPLIERS - SERVICE PROVIDERS
  • >
  • development of diagnostics

Results for

Development of diagnostics - France

France
  1. PIXIENCE

    France

    The company PIXIENCE specializes in imaging and measuring devices for cutaneous exploration. The company is an expert in research and development of diagnostics technologies in healthcare in the areas of dermatology and dermo-cosmetics. As a specialist in 2D and 3D imaging, it markets innovative solutions for: - detecting and monitoring cancers, with dermatologists and healthcare practitioners, through its ultra high definition C-Cube 2 video-dermoscope. The assessment of in vivo and in vitro active agents for dermo-cosmetics research and assessment.- The field of health telematics through high quality cutaneous imaging des technologies. PIXIENCE makes its expertise and experience available to its clients and partners in the pharmaceutical and dermocosmetic sectors to develop bespoke devices and testing methods and its image processing algorithms for cutaneous and capillary analysis.

  2. CIDELEC

    France

    For over 20 years, CIDELEC has been developing and manufacturing sleep disorder diagnostic equipment to detect pathologies such as: OSAS, Upper Airway Resistance syndrome, micro-awakenings, mandibular advancement orthosis. CIDELEC designs ventilatory polygraphs and ambulatory or fixed polysomnographs.

  3. BIOTEM

    France

    Throughout the years, BIOTEM has developed, with a perfect acquaintance with medical research and a wide range of technologies, an expertise internationally recognized in the production of monoclonal antibody. BIOTEM is specialized in the development of three monoclonal antibodies’ types: Murine, Rabbit and Humans. Murine Monoclonal Antibody technique combines certified protocols which lead to high quality production. BIOTEM put emphasis on selection, robustness, compliance and secured process. The creation of Rabbit Monoclonal Antibody allows BIOTEM to offer high affinity and specificity results that are attractive for most challenging applications in Life Science and Diagnostics. Finally, BIOTEM develops humans’ antibodies through Ultimate Humanization Platform. This process brings therapeutic antibodies with high affinity, low predicted cross-reactivity in humans and outstanding low immunogenicity.